CALLAHAN ADVISORS, LLC – Pfizer Inc. Transaction History
CALLAHAN ADVISORS, LLC portfolio value:
$15.68M
portfolio value
CALLAHAN ADVISORS, LLC quarter portfolio value change:
-16.54%
quarter
Pfizer Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.45% | -8.99K shares | -3.57M | $43.76 | 358.35K |
| Q2 2022 | share | Decrease | -4.06% | -15.53K shares | -562K | $52.43 | 367.34K |
| Q1 2022 | share | Decrease | -3.27% | -12.92K shares | -3.55M | $51.77 | 382.87K |
| Q4 2021 | share | Increase | +10.33% | 37.05K shares | 7.94M | $58.4 | 395.80K |
| Q3 2021 | share | Increase | +4.27% | 14.70K shares | 1.95M | $42.63 | 358.74K |
| Q2 2021 | share | Increase | +1.42% | 4.81K shares | 1.18M | $38.46 | 344.03K |
| Q1 2021 | share | Increase | +1.94% | 6.46K shares | 41K | $35.24 | 339.21K |
| Q4 2020 | share | Decrease | -6.70% | -23.89K shares | -169K | $35.41 | 332.75K |
| Q3 2020 | share | Increase | +0.49% | 1.72K shares | 1.40M | $33.15 | 356.65K |
| Q2 2020 | share | Increase | +3.85% | 13.14K shares | 428K | $29.25 | 354.92K |
| Q1 2020 | share | Increase | +1.62% | 5.44K shares | -1.91M | $28.9 | 341.78K |
| Q4 2019 | share | Increase | +1.80% | 5.94K shares | 1.24M | $34.34 | 336.34K |
| Q3 2019 | share | Increase | +3.61% | 11.52K shares | -1.84M | $31.19 | 330.40K |
| Q2 2019 | share | Decrease | -0.17% | -544 shares | 235K | $37.25 | 318.87K |
| Q1 2019 | share | Increase | +2.18% | 6.8K shares | -76K | $36.2 | 319.42K |
| Q4 2018 | share | Decrease | -1.07% | -3.39K shares | -266K | $36.89 | 312.62K |
| Q3 2018 | share | Increase | +0.84% | 2.61K shares | 2.42M | $36.96 | 316.01K |
| Q2 2018 | share | Increase | +1.41% | 4.34K shares | 382K | $30.17 | 313.39K |
| Q1 2018 | share | Increase | +0.52% | 1.58K shares | -160K | $29.23 | 309.05K |
| Q4 2017 | share | Increase | +0.67% | 2.04K shares | 221K | $29.56 | 307.47K |
| Q3 2017 | share | Increase | +2.56% | 7.63K shares | 855K | $28.87 | 305.42K |
| Q2 2017 | share | Increase | +1.15% | 3.37K shares | -66K | $26.9 | 297.79K |
| Q1 2017 | share | Increase | +1.89% | 5.45K shares | 651K | $27.14 | 294.41K |
| Q4 2016 | share | Increase | +4.54% | 12.54K shares | 22K | $25.51 | 288.96K |
| Q3 2016 | share | Increase | +6.21% | 16.17K shares | 189K | $26.33 | 276.41K |
| Q2 2016 | share | Increase | +0.05% | 138 shares | 1.38M | $27.15 | 260.24K |
| Q1 2016 | share | Increase | +4.12% | 10.29K shares | -337K | $22.65 | 260.10K |